摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-chloro-6-(3-chloro-4-fluorophenyl)pyridazine | 1105194-94-2

中文名称
——
中文别名
——
英文名称
3-chloro-6-(3-chloro-4-fluorophenyl)pyridazine
英文别名
——
3-chloro-6-(3-chloro-4-fluorophenyl)pyridazine化学式
CAS
1105194-94-2
化学式
C10H5Cl2FN2
mdl
——
分子量
243.068
InChiKey
YTIABLSLZDHADY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-chloro-6-(3-chloro-4-fluorophenyl)pyridazine盐酸 、 bis-triphenylphosphine-palladium(II) chloride 、 caesium carbonate溶剂黄146 作用下, 以 1,4-二氧六环乙二醇二甲醚二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 20.0h, 生成 6-(3-chloro-4-fluorophenyl)-2-[[(2S)-4-[5-(1-piperidin-4-ylpyrazol-4-yl)pyrimidin-2-yl]morpholin-2-yl]methyl]pyridazin-3-one
    参考文献:
    名称:
    Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors
    摘要:
    We report a series of phenyl substituted pyridazin-3-ones substituted with morpholino-pyrimidines. The SAR of the phenyl was explored and their c-Met kinase and cell-based inhibitory activity toward c-Met driven cell lines were evaluated. Described herein is a potent c-Met inhibitor by structural modification of the parent morpholino-pyridazinone scaffold, with particular focus on the phenyl and pyrimidine substituents. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2014.08.067
点击查看最新优质反应信息

文献信息

  • Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors
    作者:Seung-Tae Kang、Eun-Young Kim、Raghavendra Archary、Heejung Jung、Chi Hoon Park、Chang-Soo Yun、Jong Yeon Hwang、Sang Un Choi、Chonghak Chae、Chong Ock Lee、Hyoung Rae Kim、Jae Du Ha、Dohyun Ryu、Sung Yun Cho
    DOI:10.1016/j.bmcl.2014.08.067
    日期:2014.11
    We report a series of phenyl substituted pyridazin-3-ones substituted with morpholino-pyrimidines. The SAR of the phenyl was explored and their c-Met kinase and cell-based inhibitory activity toward c-Met driven cell lines were evaluated. Described herein is a potent c-Met inhibitor by structural modification of the parent morpholino-pyridazinone scaffold, with particular focus on the phenyl and pyrimidine substituents. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多